Cricopharyngeal Dysfunction and Esophageal Diverticulum
Launched by UNIVERSITY OF CINCINNATI · Jun 13, 2017
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called Zenker's diverticulum, which is a pouch that can form in the throat and make it difficult to swallow. The trial is looking at two types of surgery: one where a surgeon uses a laser or stapler to separate this pouch from the esophagus, and another approach for patients who may not be able to have surgery but are willing to participate in follow-up care. The goal is to find out how effective these treatments are for improving swallowing difficulties.
To be eligible for this trial, patients need to have a diagnosis of cervical esophageal diverticulum, specifically Zenker's diverticulum. The trial is open to anyone between the ages of 65 to 95, regardless of whether they will undergo surgery or not. Participants can expect to receive care related to their swallowing issues and may be followed over time to see how well the treatments work. It's important to note that patients who have a certain type of endoscopic procedure will not be included in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a diagnosis of cervical esophageal diverticulum, with Zenker's as most common, or CP bar (with diagnosis of early Zenker) as indicated on an esophagram who the participating institutions enroll regardless of surgical management and future treatments. Patients undergoing open transcervical or endoscopic approach in which a laser or stapler is used to divide the common wall between the diverticulum and esophagus, or who are not surgical candidates but agree to follow-up.
- Exclusion Criteria:
- • Patients who undergo division of the common wall between the diverticulum and esophagus using flexible endoscopy will not be included in the study.
About University Of Cincinnati
The University of Cincinnati is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a robust focus on translational research, the university fosters a collaborative environment that integrates cutting-edge science with clinical practice. Its diverse team of experts, equipped with state-of-the-art facilities, is committed to exploring new therapeutic interventions aimed at improving patient outcomes. The University of Cincinnati actively engages in partnerships with industry and academia to drive forward-thinking solutions in medicine, ensuring that research findings are effectively translated into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cincinnati, Ohio, United States
Patients applied
Trial Officials
Rebecca J Howell, MD
Principal Investigator
University of Cincinnati
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials